Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
Category : Search result: Wegovy pill
First Oral Pill for Thalassaemia Approved by US FDA
The US FDA has approved mitapivat (Aqvesme), the first oral drug treating anaemia in thalassaemia at a cellular level. Indian specialists explain its transformative potential for patients, especially in high-burden India.
Universal Antivenom & Oral Pills for Snakebites in India
Dr. Kartik Sunagar's groundbreaking research offers universal antibodies and oral pills to revolutionize snakebite care in India, aiming to drastically reduce fatalities. Discover the future of treatment.
2025 Weight Loss Trend: Experts Stress Lifestyle Over Injections
As GLP-1 drugs like Ozempic launched in India, experts warn they are not a magic fix. Sustainable metabolic health requires diet, exercise, and stress management. Learn why.
Ozempic, Wegovy Reduce Food Spending, New Study Finds
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
FDA Approves Daily Wegovy Pill for Weight Loss
US FDA approves Novo Nordisk's daily Wegovy pill, an oral alternative to injections. Priced from $149, it offers 14% average weight loss. Details on cost, side effects, and how it compares to rivals.
Novo Nordisk stock jumps 7% on FDA approval for Wegovy pill
Shares of Novo Nordisk surged over 7% after its weight loss drug Wegovy pill received US FDA approval on December 22, 2025. Read the full market impact analysis.
First Weight-Loss Pill Approved in US, Priced $149/Month
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
Why Stopping Weight-Loss Jabs Feels Like 'Jumping Off a Cliff'
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
Streamer Clavicular Stopped by Police During Live Miami Stream
Kick streamer Clavicular was surrounded by police during a live IRL broadcast in Miami on December 18, 2025. Watch the viral incident unfold and its aftermath.
One Combo Pill for High BP Better Than Multiple Tablets: AHA
The American Heart Association recommends single combination pills for high blood pressure, improving adherence and reducing heart attack and stroke risk by up to 30%. Learn how this simplifies treatment.
Oral GLP-1 Pill Orforglipron Shows Weight Loss Success
Eli Lilly's oral GLP-1 drug Orforglipron offers needle-free weight management with significant results in Phase 3 trials. Discover how this tablet alternative works.
Palghar Dating App Scam: Women Arrested for Robberies
Two women arrested in Palghar for allegedly luring men via dating apps, drugging them with sleeping pills, and stealing valuables worth ₹4 lakh. Police recover stolen items.
Oral Weight-Loss Pill Orforglipron: Ozempic 2.0
Eli Lilly's daily pill orforglipron shows 12% weight loss in trials, potentially revolutionizing obesity treatment. Could this be the end of injections?
Novo Nordisk Cuts Wegovy Price, Eyes Oral Pill Launch
Novo Nordisk reduces Wegovy's price to $349 and prepares an aggressive launch for its oral weight-loss pill to combat competition from Eli Lilly and expand patient access.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy price by 37% in India, intensifying the weight loss drug war with Eli Lilly's Mounjaro. Discover the new costs and market impact.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces its weight loss drug Wegovy's price by 37% in India, intensifying competition with Eli Lilly's Mounjaro. Get the latest details on the new pricing and market dynamics.
Novo Nordisk cuts Wegovy price 37% in India
Novo Nordisk reduces Wegovy's price by 37% in India as it faces patent loss and competition from Eli Lilly's Mounjaro and upcoming generic versions. Discover the new costs.
Trump: Deal Reached to Lower Weight Loss Drug Prices
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
White House Deal Cuts Ozempic & Wegovy Prices in India
In a major breakthrough for weight management, the White House has secured a deal that significantly reduces prices of popular drugs Ozempic and Wegovy, making effective weight loss treatment more accessible across India.
FDA OKs Pill That Prevents Heart Attacks by Reducing Inflammation
Discover the groundbreaking FDA-approved medication that reduces cardiovascular risks by tackling chronic inflammation, offering new hope for millions at risk of heart attacks and strokes.
Eli Lilly's Diabetes & Weight Loss Pill Replaces Injections
Eli Lilly is developing Orforglipron oral pills for weight loss and type 2 diabetes that could replace injections, making treatment more accessible and convenient for millions.
How GLP-1 Drugs Are Quietly Reshaping America's Waistline
Discover how revolutionary GLP-1 medications including Ozempic, Wegovy, and Mounjaro are transforming America's battle against obesity, offering new hope for sustainable weight loss.
Semaglutide: Weight Loss Drug Protects Heart
Groundbreaking research shows popular weight-loss drug semaglutide significantly reduces heart disease risk, offering dual benefits for patients struggling with obesity and cardiovascular health.
Abu Dhabi Police Debunk School 'Red Pill' Rumours
Abu Dhabi Police issue urgent clarification about false social media claims regarding dangerous 'red pills' circulating in educational institutions. Authorities warn against spreading misinformation.
Abu Dhabi Police debunk viral red pill school rumour
Abu Dhabi Police issue urgent clarification after social media panic about dangerous 'red pills' circulating in educational institutions. Authorities confirm complete falsehood of viral claims.
Novo Nordisk Board Reshuffle: New Faces at the Helm
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Page 1 of 1